Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MTAC

MedTech Acquisition (MTAC) Stock Price, News & Analysis

MedTech Acquisition logo

About MedTech Acquisition Stock (NASDAQ:MTAC)

Advanced Chart

Key Stats

Today's Range
$8.96
$12.83
50-Day Range
$9.34
$11.34
52-Week Range
$8.43
$12.83
Volume
183,276 shs
Average Volume
9,656 shs
Market Capitalization
$83.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

Receive MTAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

MTAC Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
SMTI Sanara MedTech Inc.
See More Headlines

MTAC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that MedTech Acquisition investors own include Ginkgo Bioworks (DNA), BYD (BYDDY), Spire Global (SPIR), Altimeter Growth (AGC), ARK Innovation ETF (ARKK), Berkshire Hathaway (BRK.B) and Coinbase Global (COIN).

Company Calendar

Today
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:MTAC
Web
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.89 per share
Price / Cash Flow
12.80
Book Value
($2.04) per share
Price / Book
-5.56

Miscellaneous

Free Float
1,952,000
Market Cap
$83.80 million
Optionable
Not Optionable
Beta
-0.04
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MTAC) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners